Business
Oxford University to launch trial alternating coronavirus vaccines from AstraZeneca and Pfizer-BioNTech – ABC News
Oxford University will launch a trial alternating doses of COVID-19 vaccines created by different manufacturers.
Oxford University says it will launch a trial alternating doses of COVID-19 vaccines created by different manufacturers.
- The trial aims to determine whether different COVID-19 doses can be used interchangeably
- If successful, it could lead to a more flexible vaccine rollout, says the UK’s chief health officer
- Britain has been administering vaccines at an interval of 12 weeks to give more people a first dose, unlike other countries
The trial aims to determine whether different COVID-19 vaccine doses…
Continue Reading
-
General22 hours agoMaría Corina Machado awarded Nobel Peace Prize
-
Noosa News21 hours agoQueensland’s bid for net zero by 2050 unlikely under new energy plan: expert
-
General20 hours agoWestern Bulldogs extend Essendon’s losing streak with 57 point thrashing
-
Business10 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies